Pharmaceutical Technology, September 2014 Issue (PDF)

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-09-02-2014
Volume 38
Issue 9

Click the title above to open the Pharmaceutical Technology September 2014 issue in an interactive PDF format.

External Link - PharmTech_NA_Sept2014.pdf

Articles in this issue
Super-Pro-(1)-853766-1417773911676.gif
Using Ultrasonic Cleaning for Equipment and Tooling
Investigation of Various Impurities in Febuxostat
Investigation of Various Impurities in Febuxostat
Asymmetric Synthesis Continues to Advance
Asymmetric Synthesis Continues to Advance
Equation-1-853783-1416900666873.jpg
Using Quality by Design to Develop Robust Chromatographic Methods
Waters-mass-spec-853436-1416900052586.gif
Waters QTof Mass Spectrometer Detects Low-Level Compounds
Xylem-polarimeter-853325-1416900297813.gif
Xylem Polarimeters Measure Chiral Compounds
Milmo_Sean-853679-1416900804349.jpg
Extending the Scope of Pharmacovigilance Comes at a Price
Minimizing Variation in Vial Withdrawal Practice
Minimizing Variation in Vial Withdrawal Practice
Baseman_Hal120-853728-1416900735395.jpg
The Relevance of Industry Technical Associations
Thermo-Vanquish-UPHLC-853429-1416900071635.gif
Thermo Fisher Scientific UHPLC System Improves Productivity
MA3100-853444-1416900028407.gif
Excellims Ion-Mobility Separator Interfaces with Mass Spectrometers
QbD in API Manufacturing
QbD in API Manufacturing
Modularity Creates Flexible Manufacturing Systems
Modularity Creates Flexible Manufacturing Systems
PT_fitforlung200.jpg
Fit for the Lung?
Wechsler_Jill-853662-1416899808015.jpg
Data Integrity Key to GMP Compliance
Recent Videos
Drug Digest: Patient Preference Drives Solid Dosage Trends
Behind the Headlines, Episode 17
Related Content
Teva Pharmaceuticals manufacturing site. Locally, Teva produces oral solid medicines and packaging. | Image Credit: © jetcityimage - stock.adobe.com

FDA Grants Fast Track Designation to Teva Celiac Disease Candidate

Patrick Lavery
May 30th 2025
Article

Teva’s investigational monoclonal antibody, TEV-53408, has been designed for use in adults with celiac disease, for which a strict and lifelong gluten-free diet is currently the only treatment.

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Patrick Lavery
May 30th 2025
Podcast

In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.

A lab technician in protective gear operates a tablet displaying a green checkmark in a high-tech pharmaceutical laboratory. | Image Credit: © greenbutterfly - stock.adobe.com

Companies Reveal Their Next Moves in Manufacturing

Patrick Lavery
May 29th 2025
Article

In discussions at INTERPHEX 2025, company representatives seized upon several common themes, most notably safety, sustainability, and the increasing utility of automation.

Site Logo

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Site Logo

End-to-end regulatory CDMO solutions: development, manufacturing, and approval (May 2025)

Lonza
May 29th 2025
Article

Site Logo

Exploring the need for dose-flexible manufacturing

Lonza
May 29th 2025
Article